ZA966371B - The preparation of active peptides. - Google Patents

The preparation of active peptides.

Info

Publication number
ZA966371B
ZA966371B ZA9606371A ZA966371A ZA966371B ZA 966371 B ZA966371 B ZA 966371B ZA 9606371 A ZA9606371 A ZA 9606371A ZA 966371 A ZA966371 A ZA 966371A ZA 966371 B ZA966371 B ZA 966371B
Authority
ZA
South Africa
Prior art keywords
pct
preparation
sec
active peptides
formula
Prior art date
Application number
ZA9606371A
Other languages
English (en)
Inventor
Wilhelm Amberg
Harald Bernard
Ernst Buschmann
Andreas Haupt
Bernd Janssen
Ulrich Karl
Andreas Kling
Stefan Mueller
Kurt Riter
Thomas Zierke
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of ZA966371B publication Critical patent/ZA966371B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA9606371A 1995-07-28 1996-07-26 The preparation of active peptides. ZA966371B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19527575A DE19527575A1 (de) 1995-07-28 1995-07-28 Verfahren zur Herstellung von peptidischer Wirkstoffe

Publications (1)

Publication Number Publication Date
ZA966371B true ZA966371B (en) 1998-01-26

Family

ID=7767995

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9606371A ZA966371B (en) 1995-07-28 1996-07-26 The preparation of active peptides.

Country Status (15)

Country Link
US (1) US5965700A (cs)
EP (1) EP0842190B1 (cs)
JP (1) JP3941883B2 (cs)
KR (1) KR100445124B1 (cs)
AT (1) ATE185349T1 (cs)
AU (1) AU705143B2 (cs)
CA (1) CA2223911C (cs)
CZ (1) CZ293445B6 (cs)
DE (2) DE19527575A1 (cs)
ES (1) ES2138363T3 (cs)
HU (1) HU227981B1 (cs)
IL (1) IL122704A (cs)
TW (1) TW418212B (cs)
WO (1) WO1997005162A1 (cs)
ZA (1) ZA966371B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010009901A1 (en) 1996-12-11 2001-07-26 Basf Aktiengesellschaft Germany Antineoplastic peptides
US6426331B1 (en) 1998-07-08 2002-07-30 Tularik Inc. Inhibitors of STAT function
WO2001024763A2 (en) 1999-10-01 2001-04-12 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
WO2001083517A1 (en) * 2000-05-03 2001-11-08 Tularik Inc. Stat4 and stat6 binding dipeptide derivatives
US6884782B2 (en) 2000-11-08 2005-04-26 Amgen Inc. STAT modulators
MX2024002571A (es) 2021-09-03 2024-03-20 Toray Industries Composicion farmaceutica para tratamiento y/o prevencion de cancer.
WO2024178360A2 (en) * 2023-02-23 2024-08-29 Ambrx, Inc. Auristatin analogs and antibody conjugates thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU180925B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for producing tripeptide-amides trh-analogues,effectives on the central nerve systhem
JPH03141298A (ja) * 1989-10-25 1991-06-17 M D Res Kk 活性ペプチド
EP0642530B1 (en) * 1992-05-20 1998-08-12 BASF Aktiengesellschaft Derivatives of dolastatin

Also Published As

Publication number Publication date
CA2223911C (en) 2009-03-24
KR19990035975A (ko) 1999-05-25
DE59603295D1 (de) 1999-11-11
HU227981B1 (hu) 2012-07-30
KR100445124B1 (ko) 2004-11-16
EP0842190A1 (de) 1998-05-20
AU705143B2 (en) 1999-05-13
JP3941883B2 (ja) 2007-07-04
CA2223911A1 (en) 1997-02-13
CZ293445B6 (cs) 2004-04-14
DE19527575A1 (de) 1997-01-30
US5965700A (en) 1999-10-12
ATE185349T1 (de) 1999-10-15
IL122704A (en) 2001-06-14
HUP9802570A3 (en) 1999-06-28
JPH11509850A (ja) 1999-08-31
WO1997005162A1 (de) 1997-02-13
AU6615496A (en) 1997-02-26
EP0842190B1 (de) 1999-10-06
ES2138363T3 (es) 2000-01-01
HUP9802570A2 (hu) 1999-04-28
CZ24398A3 (cs) 1998-07-15
TW418212B (en) 2001-01-11
IL122704A0 (en) 1998-08-16

Similar Documents

Publication Publication Date Title
ATE226641T1 (de) Humaner 4-1bb spezifischer humaner antikörper und diesen produzierende zellinie
AU5320196A (en) The gc1q receptor, hiv-1 gp120 region binding thereto, and r elated peptides and targeting antibodies
ZA962526B (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
AU7249198A (en) Substantially pure zonulin, a physiological modulator of mammalian tight junctions
AU699579B2 (en) New dipeptide P-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals
NO970326L (no) Fremgangsmåte for produksjon av biologisk aktivt protein
ZA966371B (en) The preparation of active peptides.
SE9101838D0 (sv) Novel peptides and their use
MX9702665A (es) Analogos del factor de crecimiento de queratinocitos.
GB9512854D0 (en) Novel formulation
CA2194582A1 (en) Novel process for the production of biologically active dimeric protein
AU6710998A (en) Process for preparing modified proteins
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
AU4876196A (en) A process for the preparation of factor ix from biological sources
DE3462692D1 (en) Pharmacologically active peptides
MX9605278A (es) Procedimiento para la inactivacion de virus en proteinas.
BR9609801A (pt) Petídos cíclicos análogos de somatostina com atividade inibitória do desenvolvimento de hormónio
NZ508812A (en) Peptides for the prevention or treatment of HIV
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
ZA953584B (en) Novel active peptide and its preparation
AU3651997A (en) Constructs and complexes of cyclin e
MX9700656A (es) Proceso novedoso para la produccion de proteina dimerica biologicamente activa.
MX9700657A (es) Nuevo proceso para la produccion de proteina biologicamente activa.
MX9800686A (es) Nueva proteina hmw humana mp52s.
MX9801756A (es) Proceso para la preparacion de derivados de rodanina benzil substituidos.